Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.

Nguyen LH, Brewster AL, Clark ME, Regnier-Golanov A, Sunnen CN, Patil VV, D'Arcangelo G, Anderson AE.

Epilepsia. 2015 Apr;56(4):636-46. doi: 10.1111/epi.12946. Epub 2015 Mar 6.

2.

Conditional Loss of Arx From the Developing Dorsal Telencephalon Results in Behavioral Phenotypes Resembling Mild Human ARX Mutations.

Simonet JC, Sunnen CN, Wu J, Golden JA, Marsh ED.

Cereb Cortex. 2015 Sep;25(9):2939-50. doi: 10.1093/cercor/bhu090. Epub 2014 May 2.

3.

Arx is required for specification of the zona incerta and reticular nucleus of the thalamus.

Sunnen CN, Simonet JC, Marsh ED, Golden JA.

J Neuropathol Exp Neurol. 2014 Mar;73(3):253-61. doi: 10.1097/NEN.0000000000000048.

4.

Development and characterization of NEX- Pten, a novel forebrain excitatory neuron-specific knockout mouse.

Kazdoba TM, Sunnen CN, Crowell B, Lee GH, Anderson AE, D'Arcangelo G.

Dev Neurosci. 2012;34(2-3):198-209. Epub 2012 May 8.

5.

Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice.

Sunnen CN, Brewster AL, Lugo JN, Vanegas F, Turcios E, Mukhi S, Parghi D, D'Arcangelo G, Anderson AE.

Epilepsia. 2011 Nov;52(11):2065-75. doi: 10.1111/j.1528-1167.2011.03280.x. Epub 2011 Oct 5.

6.

Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia.

Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G.

Dis Model Mech. 2009 Jul-Aug;2(7-8):389-98. doi: 10.1242/dmm.002386. Epub 2009 May 26.

Supplemental Content

Loading ...
Support Center